Immune modulator drugs for COVID-19 focus of major NIH clinical trial

One of the most vexing aspects of the COVID-19 pandemic is the novel coronavirus’s ability to turn the body’s immune system against the body. After the virus has been cleared from the body, the immune system sometimes continues to hurtle an arsenal of immune proteins at the already vanquished virus, creating a dangerous inflammatory response called a cytokine storm. Such cytokine storms can contribute to acute respiratory distress syndrome, multiple organ failure and death.